NEW YORK (GenomeWeb News) – Rosetta Genomics reported after the close of the market Tuesday that its second-quarter net loss rose 62 percent, as well as plans to eventually spin off its new cleantech division.

The Rehovot, Israel-based developer of microRNA-based tests brought in revenues of $14,000 for the three-month period ended June 30, compared to no revenues for the second quarter of 2008. Rosetta noted that revenues it previously reported for Parkway Clinical Laboratories, which it sold for $2.5 million during the quarter, is now recorded under discontinued operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.